European Journal of Biochemistry, Vol. 255, No. 2. (1998), pp. 472-481.
Virology, Vol. 163, No. 2. (April 1988), pp. 638-642.
Pharmacology & Therapeutics, Vol. 54, No. 3. (1992), pp. 319-355.
J. Biol. Chem., Vol. 278, No. 27. (27 June 2003), pp. 24680-24687.
Scientific American, Vol. 298, No. 1. (January 2008), pp. 56-63.
J Virol, Vol. 79, No. 5. (March 2005), pp. 2839-2846.
Virology, Vol. 337, No. 2. (5 July 2005), pp. 365-372.
Methods Mol Med, Vol. 119 (2005), pp. 445-462.
Proc Natl Acad Sci U S A, Vol. 103, No. 5. (31 January 2006), pp. 1516-1521.
Virology, Vol. 353, No. 2. (30 September 2006), pp. 451-462.
by Ligia A
Pinto, Raphael
Viscidi, Clayton D
Harro, Troy J
Kemp, Alfonso J
Garcia-Pineres, Matthew
Trivett, Franklin
Demuth, Douglas R
Lowy, John T
Schiller, Jay A
Berzofsky, Allan
Hildesheim
Clin Vaccine Immunol, Vol. 14, No. 8. (August 2007), pp. 984-989.
Lancet, Vol. 370, No. 9590. (8 September 2007), pp. 890-907.
PLoS Pathog, Vol. 2, No. 7. (July 2006)
Nature Medicine, Vol. 13, No. 7. (01 July 2007), pp. 857-861.
Clinical Immunology, Vol. 106, No. 3. (March 2003), pp. 231-237.
Virology, Vol. 307, No. 1. (1 March 2003), pp. 1-11.
J Virol, Vol. 77, No. 6. (March 2003), pp. 3531-3541.
J Virol, Vol. 75, No. 21. (November 2001), pp. 10493-10497.
J Virol, Vol. 75, No. 9. (May 2001), pp. 4332-4342.
J Virol, Vol. 72, No. 1. (January 1998), pp. 142-150.
Proc Natl Acad Sci U S A, Vol. 101, No. 39. (28 September 2004), pp. 14252-14257.
J. Virol., Vol. 80, No. 2. (15 January 2006), pp. 759-768.
Proc Natl Acad Sci U S A, Vol. 103, No. 5. (31 January 2006), pp. 1522-1527.
J Virol, Vol. 81, No. 16. (August 2007), pp. 8784-8792.
Front Biosci, Vol. 13 (2008), pp. 121-134.
Front Biosci, Vol. 13 (2008), pp. 1003-1017.
Gynecologic Oncology, Vol. 107, No. 2, Supplement 1. (November 2007), pp. S2-S5.
J Natl Cancer Inst (8 January 2008)